Ohio Administrative Code Search
| Rule |
|---|
|
Rule 4729:1-5-02 | Continuing education requirements for pharmacists.
...vided shall be an approved in-state provider of volunteer healthcare services in accordance with rule 4729-6-03 of the Administrative Code. (H) Pharmacists shall keep all certificates and other documented evidence of participation that have been issued by non-A.C.P.E. accredited providers for approved C.E.U.s for which the pharmacist has claimed continuing education units towards licensure renewa... |
|
Rule 4729:2-2-03 | Criminal records check for pharmacy interns.
...d directly to BCI&I from a WebCheck provider agency or ink impressions. The state board of pharmacy may accept the results of a criminal records check based on ink impressions only in the following circumstances: (a) Readable electronic fingerprint impressions cannot be obtained or are rejected by either BCI&I or FBI; (b) The applicant is from out-of-state; (c) The applicant's home address is seven... |
|
Rule 4729:2-3-03 | Immunization administration by pharmacy interns.
...otify the individual's primary care provider or, if the individual has no primary care provider, the board of health of the health district in which the individual resides or the authority having the duties of a board of health for that district under section 3709.05 of the Revised Code. The notice shall be given not later than thirty days after the immunization is administered. Notification s... |
|
Rule 4729:2-3-03 | Immunization administration by pharmacy interns.
...otify the individual's primary care provider or, if the individual has no primary care provider, the board of health of the health district in which the individual resides or the authority having the duties of a board of health for that district under section 3709.05 of the Revised Code. The notice shall be given not later than thirty days after the immunization is administered. Notification s... |
|
Rule 4729:2-3-06 | Dispensing of epinephrine autoinjectors by pharmacy interns.
...ng to the individual's primary care provider, if known, or to the prescriber who issued the individual the initial prescription for an epinephrine autoinjector. Notification shall be conducted using one of the following methods that is capable of confirming delivery of the required notification: (a) Electronic mail; (b) Interoperable electronic medical records system; (c) Facsimile; (d) Electr... |
|
Rule 4729:3-2-02 | Criminal Records Checks.
...d directly to BCI&I from a WebCheck provider agency or ink impressions. The state board of pharmacy may accept the results of a criminal records check based on ink impressions only in the following circumstances: (a) Readable electronic fingerprint impressions cannot be obtained or are rejected by either BCI&I or FBI; (b) The applicant is from out-of-state; or (c) The applicant's home address is se... |
|
Rule 4729:3-2-02 | Criminal records checks.
...itted directly to BCI&I from a WebCheck provider agency or ink impressions. The state board of pharmacy may accept the results of a criminal records check based on ink impressions only in the following circumstances: (1) Readable electronic fingerprint impressions cannot be obtained or are rejected by either BCI&I or FBI; (2) The applicant is from out-of-state; or (3) The applicant's home address i... |
|
Rule 4729:3-3-06 | Immunization administration by pharmacy technicians.
...harmacy education (ACPE) accredited provider. (4) The course must be a minimum of six hours in length and include, at a minimum, the following topic areas: (a) A review of immunology that includes a discussion of the body's immune system reaction to immunizations. (b) A review of each immunization recommended by the advisory committee on immunization practices of the centers for disease control... |
|
Rule 4729:3-5-01 | Continuing Education ¿ Definitions.
...experience presented by an approved provider. (C) "Continuing pharmacy education" or "continuing education", as required in section 4729.12 of the Revised Code, means post-registration pharmacy education undertaken to maintain professional competency to practice as a pharmacy technician, improve professional skills, and preserve uniform qualifications for continuing the practice of the profes... |
|
Rule 4729:3-5-02 | Continuing Education Requirements for Registered and Certified Technicians.
... provided shall be an approved in-state provider of volunteer healthcare services in accordance with agency 4729 of the Administrative Code. (D) Registered pharmacy technicians shall keep all certificates and other documented evidence of participation which have been issued by a non-A.C.P.E. accredited provider for which the pharmacy technician has claimed continuing education units towards renew... |
|
Rule 4729:4-1-01 | Definitions - impaired licensees, registrants and probation.
...tive Code. (C) "Approved treatment provider" means a designated treatment program pursuant to section 4729.18 of the Revised Code and rule 4729:4-1-03 of the Administrative Code. (D) "Business day" means any day other than Saturday, Sunday or a holiday recognized by the state of Ohio on which the offices of the board of pharmacy are not open for business. (E) "Designated person" for an ... |
|
Rule 4729:4-1-02 | Applicability.
...erson, except an approved treatment provider, shall purport to be or operate as a treatment facility for the purpose of administering care in the detoxification and rehabilitation of an impaired licensee or registrant. (B) The rules in this division of the Administrative Code are applicable to all licensed pharmacists, pharmacy interns, and any other board licensees or registrants, including phar... |
|
Rule 4729:4-1-03 | Requirements for approved treatment providers.
...(A) An approved treatment provider, as defined in rule 4729:4-1-01 of the Administrative Code, shall meet or exceed the following requirements: (1) Certification, as determined by the board, by the Ohio department of mental health and addiction services pursuant to Chapter 5119. of the Revised Code. (2) Any other treatment provider approved by the board, to include: (a) An out-of-state provider, when treatment has... |
|
Rule 4729:4-1-05 | Individual licensee or registrant probation.
...ontract with an approved monitoring provider. (6) Compliance with all terms of the approved monitoring contract, which shall include all terms set forth in rule 4729:4-1-04 of the Administrative Code. (7) Prior approval of the board or the board's probation committee of departures or absences in excess of ten days from the state or for any intended travel out of the country. Periods of depar... |
|
Rule 4729:4-1-06 | Requirements for approved monitoring programs.
...rson for the limited approved treatment provider shall: (1) Ensure confidentiality of the impaired licensee or registrant, except: (a) If the licensee or registrant fails to comply within one week to a referral for evaluation; or (b) If the impaired licensee or registrant suffers a relapse at any time during or following rehabilitation. (2) Notify the state board of pharmacy within one business day if the licens... |
|
Rule 4729:4-1-07 | Summary suspension of a licensee or registrant.
...contract from an approved treatment provider or monitoring program; (3) Resuming practice before the approved treatment provider or monitoring program has made an assessment and recommends that the licensee or registrant is capable of practicing; (4) A relapse, as defined in rule 4729:4-1-01 of the Administrative Code, of substance abuse/chemical dependency at any time. (B) An impaired lice... |
|
Rule 4729:4-1-09 | Terms while under suspension.
... contract with an approved monitoring provider. (5) Compliance with all terms of the approved monitoring contract, which shall include all terms set forth in rule 4729:4-1-04 of the Administrative Code. (6) Prior approval of the board or the board's probation committee of departures or absences in excess of ten days from the state or for any intended travel out of the country. Periods of depar... |
|
Rule 4729:5-1-01 | Definitions - terminal distributors of dangerous drugs.
...ourcing facility, third-party logistics provider, wholesale distributor, or pharmacist, who has possession, custody, or control of dangerous drugs for any purpose other than for that person's own use and consumption. (1) A terminal distributor of dangerous drugs includes pharmacies, hospitals, nursing homes, and laboratories and all other persons who procure dangerous drugs for sale or other ... |
|
Rule 4729:5-1-01 | Definitions - terminal distributors of dangerous drugs.
...ourcing facility, third-party logistics provider, wholesale distributor, or pharmacist, who has possession, custody, or control of dangerous drugs for any purpose other than for that person's own use and consumption. (1) A terminal distributor of dangerous drugs includes pharmacies, hospitals, nursing homes, and laboratories and all other persons who procure dangerous drugs for sale or other ... |
|
Rule 4729:5-1-01 | Definitions - terminal distributors of dangerous drugs.
...ourcing facility, third-party logistics provider, wholesale distributor, or pharmacist, who has possession, custody, or control of dangerous drugs for any purpose other than for that person's own use and consumption. (1) A terminal distributor of dangerous drugs includes pharmacies, hospitals, nursing homes, and laboratories and all other persons who procure dangerous drugs for sale or other ... |
|
Rule 4729:5-3-04 | Verification of licensure prior to sale or purchase.
...ing facility, third-party logistics provider, repackager, or wholesale distributor that is located in another state, is not engaged in the sale of dangerous drugs within this state, and is actively licensed to engage in the sale of dangerous drugs by the state in which the distributor conducts business; or (2) Any of the exempted persons described in section 4729.541 of the Revised Code. (E) A t... |
|
Rule 4729:5-3-04 | Verification of licensure prior to sale or purchase.
...ing facility, third-party logistics provider, repackager, or wholesale distributor that is located in another state, is not engaged in the sale of dangerous drugs within this state, and is actively licensed to engage in the sale of dangerous drugs by the state in which the distributor conducts business; or (2) Any of the exempted persons described in section 4729.541 of the Revised Code. (3) The... |
|
Rule 4729:5-3-05 | Confidentiality of patient records.
...ent of the pharmacist or healthcare provider, it is deemed to be in the best interest of the patient. A pharmacist or healthcare provider making an oral disclosure in an emergency situation must prepare a written memorandum showing the patient's name, the date and time the disclosure was made, the nature of the emergency, and the names of the individuals by whom and to whom the information was ... |
|
Rule 4729:5-3-05 | Confidentiality of patient records.
...ent of the pharmacist or healthcare provider, it is deemed to be in the best interest of the patient. A pharmacist or healthcare provider making an oral disclosure in an emergency situation must prepare a written memorandum showing the patient's name, the date and time the disclosure was made, the nature of the emergency, and the names of the individuals by whom and to whom the information was... |
|
Rule 4729:5-3-23 | Mobile clinics or medication units.
...d management of the licensed healthcare provider. All personally furnishing activities shall comply with the requirements of Chapter 4729:5-19 of the Administrative Code. (4) Implement a record keeping system that will provide accountability for proper receipt, delivery, disposal, and return of all prescription medications in accordance with applicable record keeping provisions in division 4729:5... |